Nov 05, 2019 4:10 pm EST CymaBay Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Nov 04, 2019 8:00 am EST CymaBay Therapeutics Reaches Target Enrollment in the ENHANCE Global Phase 3 Study Evaluating Seladelpar for Primary Biliary Cholangitis
Oct 28, 2019 8:00 am EDT CymaBay Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 5
Oct 14, 2019 8:00 am EDT CymaBay Therapeutics to Present at the H.C. Wainwright 3rd Annual NASH Investor Conference
Sep 30, 2019 8:00 am EDT CymaBay Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
Sep 03, 2019 8:00 am EDT CymaBay Therapeutics to Present at Upcoming Investor Conferences in September